AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Veves, A Falanga, V Armstrong, DG Sabolinski, ML
Citation: A. Veves et al., Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers - A prospective randomized multicenter clinical trial, DIABET CARE, 24(2), 2001, pp. 290-295

Authors: Hamdy, O Abou-Elenin, K LoGerfo, FW Horton, ES Veves, A
Citation: O. Hamdy et al., Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy, DIABET CARE, 24(2), 2001, pp. 344-349

Authors: Veves, A King, GL
Citation: A. Veves et Gl. King, Can VEGF reverse diabetic neuropathy in human subjects?, J CLIN INV, 107(10), 2001, pp. 1215-1218

Authors: Caballero, AE Lim, SC Horton, ES Veves, A
Citation: Ae. Caballero et al., Vascular abnormalities in the prediabetic state, CONTEMP CAR, 2001, pp. 65-80

Authors: Hamdy, O Abuelenin, K Veves, A
Citation: O. Hamdy et al., Micro circulation of the diabetic foot, CONTEMP CAR, 2001, pp. 431-446

Authors: Malik, RA Veves, A Walker, D Siddique, I Lye, RH Schady, W Boulton, AJM
Citation: Ra. Malik et al., Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology, ACT NEUROP, 101(4), 2001, pp. 367-374

Authors: Pham, HT Rich, J Veves, A
Citation: Ht. Pham et al., Wound healing in diabetic foot ulceration: A review and commentary, WOUNDS, 12(4), 2000, pp. 79-81

Authors: Rich, J Veves, A
Citation: J. Rich et A. Veves, Forefoot and rearfoot plantar pressures in diabetic patients: Correlation to foot ulceration, WOUNDS, 12(4), 2000, pp. 82-87

Authors: Pham, H Harkless, LB Armstrong, DG Giurini, JM Harvey, C Veves, A
Citation: H. Pham et al., Screening techniques to identify people at high risk for diabetic foot ulceration - A prospective multicenter trial, DIABET CARE, 23(5), 2000, pp. 606-611

Authors: Cavanagh, PR Buse, JB Frykberg, RG Gibbons, GW Lipsky, BA Pogach, L Reiber, GE Sheehan, P Apelqvist, J Armstrong, DG Boulton, AJM Caputo, GM Cianci, P Cohen, IK Falanga, V Foto, J Habershaw, GM Harding, KG Harkless, LB Krasner, D LoGerfo, FW Margolis, D Mayfield, JA Miller, SD Newman, L Olerud, J Ovington, LG Phillips, T Robson, MC Steed, DL Stromberg, K Ulbrecht, J Veves, A
Citation: Pr. Cavanagh et al., Consensus Development Conference on Diabetic Foot Wound Care - 7-8 April 1999, Boston, Massachusetts, J AM POD M, 89(9), 1999, pp. 475-483

Authors: Pham, HT Rosenblum, BI Lyons, TE Giurini, JM Chrzan, JS Habershaw, GM Veves, A
Citation: Ht. Pham et al., Evaluation of a human skin equivalent for the treatment of diabetic foot ulcers in a prospective, randomized, clinical trial, WOUNDS, 11(4), 1999, pp. 79-86

Authors: Veves, A
Citation: A. Veves, Regarding "Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia" - Reply, J VASC SURG, 29(5), 1999, pp. 943-943

Authors: Lim, SC Caballero, AE Smakowshi, P LoGerfo, FW Horton, ES Veves, A
Citation: Sc. Lim et al., Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria, DIABET CARE, 22(11), 1999, pp. 1865-1870

Authors: Lim, SC Caballero, AE Arora, S Smakowski, P Bashoff, EM Brown, FM Logerfo, FW Horton, ES Veves, A
Citation: Sc. Lim et al., The effect of hormonal replacement therapy on the vascular reactivity and endothelial function of healthy individuals and individuals with type 2 diabetes, J CLIN END, 84(11), 1999, pp. 4159-4164

Authors: Caballero, AE Arora, S Saouaf, R Lim, SC Smakowski, P Park, JY King, GL LoGerfo, FW Horton, ES Veves, A
Citation: Ae. Caballero et al., Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes, DIABETES, 48(9), 1999, pp. 1856-1862
Risultati: 1-15 |